Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.

After cannabis policy legalization, incident cases of schizophrenia linked to cannabis use disorder nearly tripled. Evidence ...

“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...

New research provides the first direct evidence that brain lesions causing secondary psychosis map to a common brain circuit ...

The proportion of new schizophrenia cases linked to cannabis use in Ontario, Canada, increased from 4% prior to legalization to 10% following. | Cannabis Sciences ...

Our study investigated the brain circuits involved in psychosis-a condition characterized by delusions, hallucinations, ...

A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...

We often think about diseases in terms of the symptoms they present. A cold might give you the sniffles or even GI distress, while malaria can give you fever, chills, or nausea, for example. These ...

The incidence of cannabis use disorder associated with schizophrenia almost tripled among Canadian teenagers and adults after ...

Caplyta is a prescription drug used to treat schizophrenia and bipolar disorder. Learn how long it takes the drug to work and how long it stays in your system.

If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...

Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...